Galectin-3 and post-myocardial infarction cardiac remodeling

被引:68
作者
Meijers, Wouter C. [1 ]
van der Velde, A. Rogier [1 ]
Pascual-Figal, Domingo A. [2 ]
de Boer, Rudolf A. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands
[2] Univ Murcia, Univ Hosp Virgen de la Arrixaca, Dept Cardiol, E-30001 Murcia, Spain
关键词
Galectin-3; Myocardial infarction; Heart failure; Fibrosis; Remodeling; Biomarker; ACUTE MYOCARDIAL-INFARCTION; ANGIOTENSIN-CONVERTING ENZYME; PERCUTANEOUS CORONARY INTERVENTION; LEFT-VENTRICULAR DYSFUNCTION; CHRONIC HEART-FAILURE; PHARMACOLOGICAL INHIBITION; FIBROSIS; ALDOSTERONE; ACTIVATION; EXPRESSION;
D O I
10.1016/j.ejphar.2015.06.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review summarizes the current literature regarding the involvement and the putative role(s) of galectin-3 in post-myocardial infarction cardiac remodeling. Post-myocardial infarction remodeling is characterized by acute loss of myocardium, which leads to structural and biomechanical changes in order to preserve cardiac function. A hallmark herein is fibrosis formation, both in the early and late phase following acute myocardial infarction. Galectin-3, a P-galactoside-binding lectin, which is a shared factor in fibrosis formation in multiple organs, has an established role in cardiac fibrosis in the setting of pressure overload, neuro-endocrine activation and hypertension, but its role in post- myocardial infarction remodeling has received less attention. However, accumulative experimental studies have shown that myocardial galectin-3 expression is upregulated after myocardial infarction, both on mRNA and protein level. This already occurs shortly after myocardial infarction in the infarcted and border zone area, and also at a later stage in the spared myocarclium, contributing to tissue repair and fibrosis. This is associated with typical aspects of fibrosis formation, such as apposition of matricellular proteins and increased factors of collagen turnover. Interestingly, myocardial fibrosis in experimental post-myocardial infarction cardiac remodeling could be attenuated by galectin-3 inhibition. In clinical studies, circulating galectin-3 levels have been shown to identify patients at risk for new-onset heart failure and atrial fibrillation. Circulating galectin-3 levels also predict progressive left ventricular dilatation after myocardial infarction. From literature we conclude that galectin-3 is an active player in cardiac remodeling after myocardial infarction. Future studies should focus on the dynamics of galectin-3 activation after myocardial infarction, and study the possibilities to target galectin-3. (C) 2015 Elsevier By. All rights reserved.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 67 条
[1]   A systematic review: Effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction [J].
Abdulla, Jawdat ;
Barlera, Simona ;
Latini, Roberto ;
Kjoller-Hansen, Lars ;
Sogaard, Peter ;
Christensen, Erik ;
Kober, Lars ;
Torp-Pedersen, Christian .
EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (02) :129-135
[2]   Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT [J].
Anand, Inder S. ;
Rector, Thomas S. ;
Kuskowski, Michael ;
Adourian, Aram ;
Muntendam, Pieter ;
Cohn, Jay N. .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (05) :511-518
[3]   Relationships Between Biomarkers and Left Ventricular Filling Pressures at Rest and During Exercise in Patients After Myocardial Infarction [J].
Andersen, Mads J. ;
Ersboll, Mads ;
Bro-Jeppesen, John ;
Moller, Jacob E. ;
Hassager, Christian ;
Kober, Lars ;
Borlaug, Barry A. ;
Goetze, Jens P. ;
Gustafsson, Finn .
JOURNAL OF CARDIAC FAILURE, 2014, 20 (12) :959-967
[4]  
[Anonymous], 2011, WHO I Global atlas on cardiovascular disease prevention and control
[5]   ECM remodeling in hypertensive heart disease [J].
Berk, Bradford C. ;
Fujiwara, Keigi ;
Lehoux, Stephanie .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) :568-575
[6]   The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries [J].
Calvier, Laurent ;
Martinez-Martinez, Ernesto ;
Miana, Maria ;
Cachofeiro, Victoria ;
Rousseau, Elodie ;
Rafael Sadaba, J. ;
Zannad, Faiez ;
Rossignol, Patrick ;
Lopez-Andres, Natalia .
JACC-HEART FAILURE, 2015, 3 (01) :59-67
[7]   Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis [J].
Calvier, Laurent ;
Miana, Maria ;
Reboul, Pascal ;
Cachofeiro, Victoria ;
Martinez-Martinez, Ernesto ;
de Boer, Rudolf A. ;
Poirier, Francoise ;
Lacolley, Patrick ;
Zannad, Faiez ;
Rossignol, Patrick ;
Lopez-Andres, Natalia .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (01) :67-+
[8]   RELATION OF INITIAL INFARCT SIZE TO EXTENT OF LEFT-VENTRICULAR REMODELING IN THE YEAR AFTER ACUTE MYOCARDIAL-INFARCTION [J].
CHAREONTHAITAWEE, P ;
CHRISTIAN, TF ;
HIROSE, K ;
GIBBONS, RJ ;
RUMBERGER, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (03) :567-573
[9]   REGULATION OF COLLAGEN DEGRADATION IN THE RAT MYOCARDIUM AFTER INFARCTION [J].
CLEUTJENS, JPM ;
KANDALA, JC ;
GUARDA, E ;
GUNTAKA, RV ;
WEBER, KT .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (06) :1281-1292
[10]   Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity [J].
Cui, Wenpeng ;
Maimaitiyiming, Hasiyeti ;
Qi, Xinyu ;
Norman, Heather ;
Wang, Shuxia .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 305 (06) :F871-F880